Groundbreaking Alzheimer’s drug not cost-effective ‘at any price’ – NCPE
“We know that this news will be disappointing for families affected by dementia,” says Alzheimer Society of Ireland.…
Price reductions needed to make groundbreaking Alzheimer’s drugs available – study
Irish study of 174 countries finds that the real-world impact of innovative treatments will depend on whether they…
Less than 20% of patients in Japan interested in new Alzheimer’s drugs received one
Less than 20% of people who showed interest in taking new medications for Alzheimer’s disease went on to…